Can benzodiazepines alone cause respiratory depression in an elderly female patient with Chronic Obstructive Pulmonary Disease (COPD) and anxiety, particularly with Xanax (alprazolam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Benzodiazepines alone can cause respiratory depression, particularly at high doses, and their use should be approached with caution in elderly patients with COPD and anxiety. For an elderly female with COPD and anxiety, I would recommend starting with a very low dose of a shorter-acting benzodiazepine, such as lorazepam (Ativan) 0.25-0.5 mg once or twice daily as needed, rather than Xanax (alprazolam) 1. The most recent evidence suggests that benzodiazepines have been associated with increased risk of all-cause mortality in severe COPD and other morbidity such as falls, and therefore should be used as second- or third-line therapy, in acute episodes when other measures have failed and anxiety significantly aggravates distress 1. Some key points to consider when prescribing benzodiazepines in this population include:

  • Using the lowest effective dose for the shortest duration possible
  • Regular monitoring of respiratory status and cognitive function
  • Considering non-benzodiazepine alternatives like buspirone (10-15 mg twice daily) or an SSRI such as sertraline (starting at 25 mg daily) for long-term anxiety management
  • Being aware of the potential for benzodiazepines to suppress respiratory drive and worsen hypoxemia in COPD patients
  • Recognizing that elderly patients have altered pharmacokinetics with decreased drug clearance, making them more susceptible to adverse effects 1. It's also important to note that pulmonary rehabilitation has been shown to be effective in reducing symptoms of anxiety and depression in patients with COPD, and may be a useful adjunct to pharmacologic treatment 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Benzodiazepines and Respiratory Depression

  • Benzodiazepines can cause respiratory depression, especially in elderly patients with chronic obstructive pulmonary disease (COPD) 2.
  • The risk of respiratory depression increases with the dose and duration of benzodiazepine use 2.
  • Benzodiazepines should be used with caution in patients with COPD, and the lowest effective dose should be prescribed for the shortest possible duration 2.

Dosage for Elderly Female with COPD and Anxiety

  • There is no specific dosage recommendation for benzodiazepines in elderly females with COPD and anxiety 3, 2, 4.
  • However, it is recommended to start with a low dose and titrate upwards as needed, while closely monitoring the patient for signs of respiratory depression and other adverse effects 2.
  • The use of benzodiazepines, such as Xanax (alprazolam), should be carefully considered in patients with COPD, and alternative treatments should be explored whenever possible 2, 5.

Xanax (Alprazolam) and COPD

  • Xanax (alprazolam) is a benzodiazepine that can cause respiratory depression, especially in elderly patients with COPD 2.
  • The use of Xanax (alprazolam) in patients with COPD should be carefully considered, and the lowest effective dose should be prescribed for the shortest possible duration 2.
  • Alternative treatments, such as selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), may be considered for the management of anxiety in patients with COPD 3, 4, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.